- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 폐 합병증 in Japan
총 504 건
-
AstraZenecaMitsubishi Tanabe Pharma Corporation완전한
-
AstraZenecaMitsubishi Tanabe Pharma Corporation완전한
-
Translational Research Center for Medical Innovation...Kobe City Medical Center General Hospital완전한
-
Eisai Co., Ltd.완전한
-
Translational Research Center for Medical Innovation...Kobe City Medical Center General Hospital완전한
-
GlaxoSmithKline완전한
-
Novartis Pharmaceuticals완전한만성 폐쇄성 폐질환벨기에, 프랑스, 일본
-
Niigata University Medical & Dental Hospital완전한
-
Boehringer Ingelheim완전한
-
Aarhus University HospitalNagoya University; Department of Pulmonary Circulation and Thromboembolic Diseases, Medical...모병
-
GlaxoSmithKline완전한
-
Tjip van der WerfGadjah Mada University; The Enose Company, Zutphen the Netherlands완전한Pulmonary Tuberculosis Suspected | Other Specified Chronic Obstructive Pulmonary Disease | Pulmonary Tuberculosis TB (+) Histology, (-) Bacteriology인도네시아
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan완전한
-
Novartis Pharmaceuticals완전한
-
International University of Health and WelfareJapan Agency for Medical Research and Development; Chugai Pharmaceutical; Keio University모병
-
Idorsia Pharmaceuticals Ltd.종료됨
-
Bayer완전한고혈압, 폐일본, 독일, 스웨덴, 콜롬비아, 칠면조, 벨기에, 캐나다
-
Pfizer's Upjohn has merged with Mylan to form Viatris...완전한
-
AstraZenecaLinical Co., Ltd.완전한
-
National Hospital Organization Okayama Medical...Bayer Yakuhin, Ltd.모병
-
AstraZenecaLinical Co., Ltd.완전한
-
Kurume University알려지지 않은당뇨병 합병증에 대한 보호 작용에 대한 DPP-4 억제제 또는 SGLT2 억제제의 효과일본
-
GlaxoSmithKline완전한